Trials / Withdrawn
WithdrawnNCT04128852
Post Marketing Clinical Follow up Study for MagnetOs Putty in Patients With Degenerative Disc Disease
A Prospective, Single Arm, Single-center Study to Assess the Safety and Performance of MagnetOs Putty in Patients Undergoing Single/Two-level Lateral Lumbar Interbody Fusion
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Kuros Biosurgery AG · Industry
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a post-marketing clinical follow-up study for MagnetOs Putty. MagnetOs Putty is a synthetic bone-like material which is routinely used by surgeons as a treatment for patients with degenerative disc disease who will undergo surgery for spinal fusion (extreme lateral interbody fusion (XLIF). MagnetOs Putty will be used according to the instructions for use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MagnetOs Putty | MagnetOs Putty has a CE-mark (2115660CE01) as well as FDA 510(k) clearance (K171563/K181958). |
Timeline
- Start date
- 2020-11-11
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2019-10-16
- Last updated
- 2024-02-13
Source: ClinicalTrials.gov record NCT04128852. Inclusion in this directory is not an endorsement.